Killian Meara

A Q&A surrounding the two technologies with investigators from the Wistar Institute.

Cooler weather and higher population density were linked with higher transmission.

Entry bans, travel bans and lock downs all helped to curb the spread of the virus.

The extension changes the shelf life from 3 months to 4.5 months.

The therapy was associated with reduced mortality, cellular senescence and inflammatory markers.

The agreement brings the total number of doses bought by the United States to 800 million.

The public health agency eased travel recommendations for over 110 countries.

Diets consisting mainly of pants and fish were associated with lower chances of moderate to severe infections.

The vaccine covers 13 S. pneumoniae serotypes plus an additional 7.

Pediatric patients with COVID-19 showed higher rates of symptoms than those with influenza.

The therapy was associated with 95,000 fewer deaths through early March of 2021.

High admission plasma ACE2 was associated with an increased maximal illness severity within 28 days.

The therapy builds on the Prevnar 13 platform with an additional 7 serotypes.

Deaths continue to plunge in Brazil as more vaccinations are administered.

Regardless of age, Alzheimer’s was seen to be a risk factor for severe disease and death.

Tembexa was developed by Chimerix and showed a statistically significant survival benefit.

Those with moderate or severe obesity had a greater risk of hospitalization at 10-month follow up.

Metal ions in the body help to form a bridge between viral mRNA and viral proteins.

Antibodies produced by memory B cells remembering an older infection could help develop new therapies.

Participants taking methotrexate for an immune disorder did not show an increase in CD8 T cells.

Mice treated with diABZI showed reduced weight loss and reduced viral load in the lungs and nostrils.

Maintaining non-pharmaceutical interventions were seen to reduce the spread of infections during computer modeling.

No evidence of an association between genetically predicted vitamin D levels and COVID-19 susceptibility were found in the study.

Younger participants in the study had a higher percentage of stokes than seen in the general population.

Hamsters treated with the therapy did not lose any bodyweight and had reduced virus particles in their lungs.

Worries mount in Africa as only 2% of the population has received a vaccine.

Rates of acute myocardial infarction were higher in those with genetic risks for familial hypercholesterolemia.

Patients with hypoxemia or tachypnea had an overall greater mortality risk compared to those without them.

Participants with a prior case of disease showed cells in their bone marrow up to 4 months after their initial infection.

Sotrovimab was developed by GlaxoSmithKline and Vir Biotechnology to treat mild-to-moderate disease in adults and pediatric patients.